Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-002000
Filing Date
2022-01-05
Accepted
2022-01-05 19:34:08
Documents
1
Period of Report
2022-01-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6066
  Complete submission text file 0001209191-22-002000.txt   7442
Mailing Address 1616 EASTLAKE AVE E, SUITE 208 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE E, SUITE 208 SEATTLE WA 98102 (206) 737-0085
Icosavax, Inc. (Issuer) CIK: 0001786255 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ICOSAVAX, INC. 1616 EASTLAKE AVENUE E. SUITE 208 SEATTLE WA 98102
Business Address
Shiver John W. (Reporting) CIK: 0001900372 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40655 | Film No.: 22513145